Insight

Aug 31, 2024, 20:07

5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:

RET rearrangements detection by FISH compared to other techniques in non-small cell lung cancer

Authors: A. Mc Leer, J. Mondet, N. Magnat, M. Mersch, D. Giovannini, C. Emprou, A.C. Toffart, N. Sturm, S. Lantuéjoul, D. Benito

Stephen Liu

Eftilagimod Alpha (a Soluble LAG-3 Protein) plus Pembrolizumab in Second-Line Metastatic Non-Small Cell Lung Cancer Refractory to Anti-PD-(L)1-based Therapy: Final Results from a Phase II Study

Authors: M.G. Krebs, M. Forster, M. Majem, J. Peguero, W. Iams, T. Clay, P. Roxburgh, B. Doger, P. Bajaj, B. Andres, S. Perera, C. Mueller, F. Triebel

Stephen Liu

Efficacy and safety of pralsetinib in patients with RET fusion positive non–small cell lung cancer: An observational real world study

Authors: Dehua Liao, Minghui Long, Jiwen Zhang, Xingyu Wei, Fei Li, Ting Yan, Desong Yang

Stephen Liu

Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update

Authors: Afshin Dowlati et al.

Stephen Liu

Real-World Biomarker Test Ordering Practices in Non–Small Cell Lung Cancer: Interphysician Variation and Association With Clinical Outcomes

Authors: Jason Baron, Sarrah Widatalla, Matthew Gubens, Farah Khalil

Stephen Liu

Follow Stephen Liu on X for more such content.

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.

A. Mc Leer A.C. Toffart Afshin Dowlati Amanda Parkes B. Andres B. Doger C. Emprou C. Mueller cancer D. Benito D. Giovannini Dehua Liao Desong Yang Enriqueta Felip F. Triebel Farah Khalil Fei Li Hasna Bouchaab Hiroki Izumi Horst-Dieter Hummel Hossein Borghaei J. Mondet J. Peguero Jason Baron Jiwen Zhang Kai He Luis Paz-Ares M. Forster M. Majem M. Mersch M.G. Krebs Maria Eugenia Olmedo Matthew Gubens Melissa L. Johnson Michael Boyer Minghui Long N. Magnat N. Sturm Neeltje Steeghs NSCLC OncoDaily Oncology P. Bajaj P. Roxburgh Pablo Martinez Philipp J. Jost S. Lantuéjoul S. Perera Sarrah Widatalla SCLC Shirish Gadgeel Stephane Champiat Stephen Liu T. Clay Tatsuya Yoshida Ting Yan W. Iams Xi Chen Xingyu Wei Youfei Yu

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage